AACE: Islet Cell Transplants for Type 1 Diabetes Promising
Majority of transplant recipients had near-normal metabolic control
Publish date: May 16, 2008
Individuals with type 1 diabetes who undergo islet cell transplant have near-normalization of metabolic control and fewer episodes of hypoglycemia, according to research presented this week at the American Association of Clinical Endocrinologists (AACE) 17th Annual Meeting & Clinical Congress held in Orlando, Fla.